538 related articles for article (PubMed ID: 27209361)
1. Withania somnifera and Its Withanolides Attenuate Oxidative and Inflammatory Responses and Up-Regulate Antioxidant Responses in BV-2 Microglial Cells.
Sun GY; Li R; Cui J; Hannink M; Gu Z; Fritsche KL; Lubahn DB; Simonyi A
Neuromolecular Med; 2016 Sep; 18(3):241-52. PubMed ID: 27209361
[TBL] [Abstract][Full Text] [Related]
2. Phytochemicals and botanical extracts regulate NF-κB and Nrf2/ARE reporter activities in DI TNC1 astrocytes.
Ajit D; Simonyi A; Li R; Chen Z; Hannink M; Fritsche KL; Mossine VV; Smith RE; Dobbs TK; Luo R; Folk WR; Gu Z; Lubahn DB; Weisman GA; Sun GY
Neurochem Int; 2016 Jul; 97():49-56. PubMed ID: 27166148
[TBL] [Abstract][Full Text] [Related]
3. Revisiting the Multifaceted Therapeutic Potential of Withaferin A (WA), a Novel Steroidal Lactone, W-ferinAmax Ashwagandha, from
Kumar P; Banik SP; Goel A; Chakraborty S; Bagchi M; Bagchi D
J Am Nutr Assoc; 2024 Feb; 43(2):115-130. PubMed ID: 37410676
[No Abstract] [Full Text] [Related]
4. In vitro protective effects of Withania somnifera (L.) dunal root extract against hydrogen peroxide and β-amyloid(1-42)-induced cytotoxicity in differentiated PC12 cells.
Kumar S; Seal CJ; Howes MJ; Kite GC; Okello EJ
Phytother Res; 2010 Oct; 24(10):1567-74. PubMed ID: 20680931
[TBL] [Abstract][Full Text] [Related]
5. Aqueous extract from the Withania somnifera leaves as a potential anti-neuroinflammatory agent: a mechanistic study.
Gupta M; Kaur G
J Neuroinflammation; 2016 Aug; 13(1):193. PubMed ID: 27550017
[TBL] [Abstract][Full Text] [Related]
6. Withanolides against TLR4-Activated Innate Inflammatory Signalling Pathways: A Comparative Computational and Experimental Study.
Purushotham PM; Kim JM; Jo EK; Senthil K
Phytother Res; 2017 Jan; 31(1):152-163. PubMed ID: 27859734
[TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacokinetic evaluation of Withania somnifera (L.) Dunal root extract in healthy human volunteers: A non-randomized, single dose study utilizing UHPLC-MS/MS analysis.
Vaidya VG; Naik NN; Ganu G; Parmar V; Jagtap S; Saste G; Bhatt A; Mulay V; Girme A; Modi SJ; Hingorani L
J Ethnopharmacol; 2024 Mar; 322():117603. PubMed ID: 38122911
[TBL] [Abstract][Full Text] [Related]
8. Standardized root extract of Withania somnifera and Withanolide A exert moderate vasorelaxant effect in the rat aortic rings by enhancing nitric oxide generation.
Pathak P; Shukla P; Kanshana JS; Jagavelu K; Sangwan NS; Dwivedi AK; Dikshit M
J Ethnopharmacol; 2021 Oct; 278():114296. PubMed ID: 34090907
[TBL] [Abstract][Full Text] [Related]
9. Hydrangenol inhibits lipopolysaccharide-induced nitric oxide production in BV2 microglial cells by suppressing the NF-κB pathway and activating the Nrf2-mediated HO-1 pathway.
Kim HJ; Kang CH; Jayasooriya RGPT; Dilshara MG; Lee S; Choi YH; Seo YT; Kim GY
Int Immunopharmacol; 2016 Jun; 35():61-69. PubMed ID: 27032067
[TBL] [Abstract][Full Text] [Related]
10. Unveiling anti-oxidative and anti-inflammatory effects of docosahexaenoic acid and its lipid peroxidation product on lipopolysaccharide-stimulated BV-2 microglial cells.
Yang B; Li R; Michael Greenlief C; Fritsche KL; Gu Z; Cui J; Lee JC; Beversdorf DQ; Sun GY
J Neuroinflammation; 2018 Jul; 15(1):202. PubMed ID: 29986724
[TBL] [Abstract][Full Text] [Related]
11. Exploration of immunomodulatory and protective effect of Withania somnifera on trace metal oxide (zinc oxide nanoparticles) induced toxicity in Balb/c mice.
Kumar J; Mitra MD; Hussain A; Kaul G
Mol Biol Rep; 2019 Apr; 46(2):2447-2459. PubMed ID: 30847852
[TBL] [Abstract][Full Text] [Related]
12. Withanolides potentiate apoptosis, inhibit invasion, and abolish osteoclastogenesis through suppression of nuclear factor-kappaB (NF-kappaB) activation and NF-kappaB-regulated gene expression.
Ichikawa H; Takada Y; Shishodia S; Jayaprakasam B; Nair MG; Aggarwal BB
Mol Cancer Ther; 2006 Jun; 5(6):1434-45. PubMed ID: 16818501
[TBL] [Abstract][Full Text] [Related]
13. Quercetin inhibits lipopolysaccharide-induced nitric oxide production in BV2 microglial cells by suppressing the NF-κB pathway and activating the Nrf2-dependent HO-1 pathway.
Kang CH; Choi YH; Moon SK; Kim WJ; Kim GY
Int Immunopharmacol; 2013 Nov; 17(3):808-13. PubMed ID: 24076371
[TBL] [Abstract][Full Text] [Related]
14. Withania somnifera inhibits NF-kappaB and AP-1 transcription factors in human peripheral blood and synovial fluid mononuclear cells.
Singh D; Aggarwal A; Maurya R; Naik S
Phytother Res; 2007 Oct; 21(10):905-13. PubMed ID: 17562568
[TBL] [Abstract][Full Text] [Related]
15. Extraction Optimization for Phenolic- and Withanolide-Rich Fractions from
Kumar S; Singh R; Gajbhiye N; Dhanani T
J AOAC Int; 2018 Nov; 101(6):1773-1780. PubMed ID: 29945694
[No Abstract] [Full Text] [Related]
16. Withania somnifera (L.) Dunal - Modern perspectives of an ancient Rasayana from Ayurveda.
Mukherjee PK; Banerjee S; Biswas S; Das B; Kar A; Katiyar CK
J Ethnopharmacol; 2021 Jan; 264():113157. PubMed ID: 32783987
[TBL] [Abstract][Full Text] [Related]
17. Metabolite Profiling in Withania somnifera Roots Hydroalcoholic Extract Using LC/MS, GC/MS and NMR Spectroscopy.
Trivedi MK; Panda P; Sethi KK; Jana S
Chem Biodivers; 2017 Mar; 14(3):. PubMed ID: 27743505
[TBL] [Abstract][Full Text] [Related]
18. Antagonistic effects of acetylshikonin on LPS-induced NO and PGE2 production in BV2 microglial cells via inhibition of ROS/PI3K/Akt-mediated NF-κB signaling and activation of Nrf2-dependent HO-1.
Jayasooriya RG; Lee KT; Choi YH; Moon SK; Kim WJ; Kim GY
In Vitro Cell Dev Biol Anim; 2015 Oct; 51(9):975-86. PubMed ID: 26091627
[TBL] [Abstract][Full Text] [Related]
19. Review on anticancerous therapeutic potential of Withania somnifera (L.) Dunal.
Singh N; Yadav SS; Rao AS; Nandal A; Kumar S; Ganaie SA; Narasihman B
J Ethnopharmacol; 2021 Apr; 270():113704. PubMed ID: 33359918
[TBL] [Abstract][Full Text] [Related]
20. An updated review on phytochemistry and molecular targets of
Bashir A; Nabi M; Tabassum N; Afzal S; Ayoub M
Front Pharmacol; 2023; 14():1049334. PubMed ID: 37063285
[No Abstract] [Full Text] [Related]
[Next] [New Search]
